Patents-Review.com
ClassID:

110905 ⎘

C12N2760/18151 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Avulavirus, e.g. Newcastle disease virus Methods of production or purification of viral material

Sub-classes:
Recent Application in this class:
#1
20220267738
2022-08-25

Method for purifying an enveloped virus

 #2
20180135026
2018-05-17

DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE PRODUCTION OF VIRAL VACCINES

 #3
20170049880
2017-02-23

Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector

 #4
20170037379
2017-02-09

Chimeric viruses presenting non-native surface proteins and uses thereof

 #5
20160257940
2016-09-08

Method of making a virus using duck embryonic derived stem cell lines

 #6
20140287496
2014-09-25

Heat-resistant newcastle disease virus live vaccine vector system and use thereof

 #7
20120122185
2012-05-17

Chimeric viruses presenting non-native surface proteins and uses thereof

 #8
20120058538
2012-03-08

Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems

 #9
20110195480
2011-08-11

Production of hemagglutinin-neuraminidase protein in microalgae

 #10
20100062489
2010-03-11

DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE PRODUCTION OF VIRAL VACCINES

 #11
20100047329
2010-02-25

Novel Vaccination Carrier

 #12
20090226487
2009-09-10

AVIAN EMBRYO PARTICULATE BIOMASS FOR THE PRODUCTION OF VIRUS ANTIGENS

 #13
20090180993
2009-07-16

ADMINISTRATION OF THERAPEUTIC VIRUSES

 #14
20090081161
2009-03-26

Infection and treatment of neoplasms with vesicular stomatitis virus

 #15
20090061521
2009-03-05

Recombinant negative strand RNA virus expression systems and vaccines

 #16
20080166784
2008-07-10

Stable and filterable enveloped virus formulations

 #17
20080102507
2008-05-01

Avian embryo particulate biomass for the production of virus antigens

 #18
20050220818
2005-10-06

Administration of therapeutic viruses